ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Bernard Hausen
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demertzis, S.
Right arrow Articles by Schäfers, H.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demertzis, S.
Right arrow Articles by Schäfers, H.-J.

Ann Thorac Surg 2000;70:1684-1689
© 2000 The Society of Thoracic Surgeons

Original articles: general thoracic

Ascorbic acid for amelioration of reperfusion injury in a lung autotransplantation model in sheep

Stefanos Demertzis, MD, PhDa, Mirella Scherer, MDa, Frank Langer, MDa, Alexander Dwenger, PhDa, Bernard Hausen, MD, PhDa, Hans-Joachim Schäfers, MD, PhDa

a Department of Thoracic and Cardiovascular Surgery, University Hospitals, Homburg/Saar, Germany

Address reprint requests to Dr Demertzis, Cardiocentro Ticino, Via Tesserete 48, CH-6900 Lugano, Switzerland
e-mail: stef.dem{at}mailcity.com

Background. Reperfusion injury is the leading cause of early graft dysfunction after lung transplantation. Activation of neutrophilic granulocytes with generation of free oxygen radicals appears to play a key role in this process. The efficacy of ascorbic acid as an antioxidant in the amelioration of reperfusion injury after lung transplantation has not been studied yet.

Methods. An in situ autotransplantation model in sheep is presented. The left lung was flushed (Euro-Collins solution) and reperfused; after 2 hours of cold storage, the right hilus was then clamped (group R [reference], n = 6). Group AA animals (n = 6) were treated with 1 g/kg ascorbic acid before reperfusion. Controls (group C, n = 6) underwent hilar preparation and instrumentation only.

Results. In group R, arterio-alveolar oxygen difference (AaDO2) and pulmonary vascular resistance (PVR) were significantly elevated after reperfusion. Five of 6 animals developed frank alveolar edema. All biochemical parameters showed significant PMN activation. In group AA, AaDO2, PVR, work of breathing, and the level of PMN activation were significantly lower.

Conclusions. The experimental model reproduces all aspects of lung reperfusion injury reliably. Ascorbic acid was able to weaken reperfusion injury in this experimental setup.




This article has been cited by other articles:


Home page
 Hum ReprodHome page
N. Sagsoz, U. Kisa, and A. Apan
Ischaemia-reperfusion injury of rat ovary and the effects of vitamin C, mannitol and verapamil
Hum. Reprod., November 1, 2002; 17(11): 2972 - 2976.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. R. Karamsetty and J. R. Klinger
NO: More Than Just a Vasodilator in Lung Transplantation
Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 1 - 5.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Scherer, S. Demertzis, F. Langer, A. Moritz, and H.-J. Schafers
C1-esterase inhibitor reduces reperfusion injury after lung transplantation
Ann. Thorac. Surg., January 1, 2002; 73(1): 233 - 238.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.